Chapin Davis Inc. Purchases 5,500 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Chapin Davis Inc. raised its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 33.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,050 shares of the company’s stock after buying an additional 5,500 shares during the quarter. Chapin Davis Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $361,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of BMEZ. B. Riley Wealth Advisors Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 4.8% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after buying an additional 796 shares during the period. Pine Valley Investments Ltd Liability Co increased its stake in shares of BlackRock Health Sciences Term Trust by 6.7% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock valued at $192,000 after purchasing an additional 822 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 24.1% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock valued at $70,000 after purchasing an additional 930 shares during the last quarter. LPL Financial LLC boosted its holdings in BlackRock Health Sciences Term Trust by 0.5% in the third quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after acquiring an additional 1,231 shares in the last quarter. Finally, Oppenheimer & Co. Inc. boosted its stake in BlackRock Health Sciences Term Trust by 2.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock worth $1,124,000 after purchasing an additional 1,536 shares in the last quarter.

BlackRock Health Sciences Term Trust Stock Performance

NYSE:BMEZ opened at 15.40 on Tuesday. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The firm has a 50-day simple moving average of 15.12 and a two-hundred day simple moving average of 15.39.

BlackRock Health Sciences Term Trust Increases Dividend

The company also recently disclosed a monthly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were issued a $0.179 dividend. This is a positive change from BlackRock Health Sciences Term Trust’s previous monthly dividend of $0.09. This represents a $2.15 dividend on an annualized basis and a yield of 13.95%. The ex-dividend date of this dividend was Friday, June 14th.

About BlackRock Health Sciences Term Trust

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Articles

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.